Lepton impact ionization for fixed kinematic conditions: Past, present and future
Physica Scripta · 20.11.2026
DOI: 10.1088/1402-4896/aec50c ↗Kurz gefasst
Fachartikel in der Zeitschrift Physica Scripta, online erschienen am 20.11.2026. Verfasst von Robert D DuBois.
Abstract (Originalsprache)
Triple (fully) differential ionization (TDCS) studies, i.e., studies where the post-collision kinematics for the scattered projectile and an ejected electron are defined, are reviewed for lepton impact. The primary interest is single ionization of atomic targets. Examples of available experimental data are chosen to illustrate the general features resulting from binary and recoil interactions for a variety of impact energies and kinematic conditions. Following a discussion of the initial studies and those performed in the following decades, all of which were for electron impact, available experimental TDCS studies for positron impact are discussed. Here, the emphasis is on differences between electron and positron impact. Following this summary of currently available information, new studies where the interest is on possible scaling of TDCS and recent investigations of kinematic parameters such as how the direction of scattering or impact parameter influences the TDCS spectra are discussed. This review concludes with suggestions for future studies, needed information, and a brief discussion of triple differential studies involving higher order processes and molecular targets.
Zitieren
APA
DuBois, R. D. (2026). Lepton impact ionization for fixed kinematic conditions: Past, present and future. Physica Scripta. https://doi.org/10.1088/1402-4896/aec50c
Vancouver
DuBois RD. Lepton impact ionization for fixed kinematic conditions: Past, present and future. Physica Scripta. 2026. doi:10.1088/1402-4896/aec50c
BibTeX
@article{DuBois2026,
author = {DuBois, Robert D},
title = {Lepton impact ionization for fixed kinematic conditions: Past, present and future},
journal = {Physica Scripta},
year = {2026},
doi = {10.1088/1402-4896/aec50c}
}
EUVIMED